masthead-image1

Transformative Diagnostics



masthead-image2

Next-Generation Therapies & Vaccines

Addressing large, unmet global markets with innovative proprietary products More »

masthead-image3

Worldwide Production & Distribution

Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »

masthead-image4

Strategic Investments

Identifying early-stage companies with potential to increase value for shareholders More »



blank line

OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.

News & Events

more news »

Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes more »

Phase 3 Data Supporting Rayaldee(TM) As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at NKF 2015 Spring Clinical Meetings more »

OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources more »

Investors

read more »

OPKO Health is an opportunistic research and development company that targets large, high-growth markets.